Impax Asset Management Group plc

Source: SEC Form 13F · as of Mar 2026

Impax Asset Management Group plc holds 29 biotech & pharma companies tracked by BioSniper, totaling $514.3M in value as of Mar 2026 (SEC Form 13F).

Companies held

29

Total value held

$514.3M

CompanySharesValue
ZTSZoetis Inc.1,311,067$155.0M
RGENREPLIGEN CORP438,468$51.7M
LLYELI LILLY & Co39,319$36.2M
LGNDLigand Pharmaceuticals Incorporated152,444$30.4M
GILDGILEAD SCIENCES, INC.210,813$29.4M
JNJJOHNSON & JOHNSON117,316$28.7M
ABTABBOTT LABORATORIES206,569$21.2M
MRKMerck & Co., Inc.150,937$18.2M
PCRXPacira BioSciences, Inc.750,027$17.0M
CRNXCrinetics Pharmaceuticals, Inc.350,000$12.7M
TECHBIO-TECHNE Corp195,000$10.2M
NBIXNEUROCRINE BIOSCIENCES INC75,000$9.9M
ARRYARRAY BIOPHARMA INC1,250,000$9.0M
ELVElevance Health Inc.30,247$8.9M
ROIVRoivant Sciences Ltd.300,000$8.3M
CYTKCYTOKINETICS INC125,000$8.2M
MMSIMerit Medical Systems Inc.100,000$6.9M
TVTXTravere Therapeutics, Inc.225,000$6.7M
BMYBRISTOL MYERS SQUIBB CO103,727$6.3M
AMGNAMGEN INC17,493$6.2M
CAHCardinal Health Inc.28,628$6.0M
ABBVAbbVie Inc.27,400$6.0M
IDXXIDEXX LABORATORIES INC /DE9,789$5.5M
BIIBBIOGEN INC.28,728$5.3M
PBHPrestige Consumer Healthcare Inc.65,000$3.9M
CORCencora Inc.6,311$2.0M
VRTXVERTEX PHARMACEUTICALS INC / MA4,134$1.8M
GMOptec International, Inc.20,475$1.5M
GEHCGE HealthCare Technologies Inc.19,852$1.4M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Impax Asset Management Group plc — Biotech 13F Holdings & Portfolio | BioSniper